Simple Screening Blood Test Assays for Cancers; Breast, Ovarian, Prostate, Colon, Lung, and Melanoma.
OTraces has blood based diagnostic detection methods for cancer that have superior predictive power, 90% for Prostate Cancer. We have data for breast, prostate, ovarian and lung all with greater than 95% predictive power. The system is fully automated for the clinical lab and in production. OTraces Active Surveillance test for low grade prostate cancer transition to aggressive is ready for final validation and market launch.